通过特征可分性判断病理图像分类中先验修正是否有效

Background and objective: Prior probability shift between training and deployment datasets challenges deep learning-based medical image classification. Standard correction methods reweight posterior probabilities to adjust prior bias, yet their benefit is inconsistent. We developed a reliability framework identifying when prior correction helps or harms performance in pathological cell image analysis. Methods: We analyzed 303 colorectal cancer specimens with CD103/CD8 immunostaining, yielding 185,432 annotated cell images across 16 cell types. ResNet models were trained under varying bias ratios (1.1-20$\times$). Feature separability was quantified using cosine similarity-based likelihood quality scores, reflecting intra- versus inter-class distinctions in learned feature spaces. Multiple linear regression, ANOVA, and generalized additive models (GAMs) evaluated associations among feature separability, prior bias, sample adequacy, and F1 performance. Results: Feature separability dominated performance ($β= 1.650$, $p < 0.001$), showing 412-fold stronger impact than prior bias ($β= 0.004$, $p = 0.018$). GAM analysis showed strong predictive power ($R^2 = 0.876$) with mostly linear trends. A quality threshold of 0.294 effectively identified cases requiring correction (AUC = 0.610). Cell types scoring $>0.5$ were robust without correction, whereas those $<0.3$ consistently required adjustment. Conclusion: Feature extraction quality, not bias magnitude, governs correction benefit. The proposed framework provides quantitative guidance for selective correction, enabling efficient deployment and reliable diagnostic AI.